Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rilonacept for the treatment of recurrent pericarditis.
Fava AM, Reyaldeen R, Lo Presti S, Goyal A, Akintoye E, Hughes D, Klein AL. Fava AM, et al. Among authors: klein al. Expert Opin Biol Ther. 2022 Jan;22(1):7-16. doi: 10.1080/14712598.2022.2005024. Epub 2022 Jan 31. Expert Opin Biol Ther. 2022. PMID: 34757872 Review.
Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.
Brucato A, Imazio M, Cremer PC, Adler Y, Maisch B, Lazaros G, Gattorno M, Caforio ALP, Marcolongo R, Emmi G, Martini A, Klein AL. Brucato A, et al. Among authors: klein al. Intern Emerg Med. 2018 Sep;13(6):839-844. doi: 10.1007/s11739-018-1907-x. Epub 2018 Jul 18. Intern Emerg Med. 2018. PMID: 30022399 Review.
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y. Imazio M, et al. Among authors: klein al. Eur J Prev Cardiol. 2020 Jun;27(9):956-964. doi: 10.1177/2047487319879534. Epub 2019 Oct 15. Eur J Prev Cardiol. 2020. PMID: 31610707 Free article.
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis.
Klein AL, Imazio M, Brucato A, Cremer P, LeWinter M, Abbate A, Lin D, Martini A, Beutler A, Chang S, Fang F, Gervais A, Perrin R, Paolini JF. Klein AL, et al. Am Heart J. 2020 Oct;228:81-90. doi: 10.1016/j.ahj.2020.07.004. Epub 2020 Jul 14. Am Heart J. 2020. PMID: 32866928 Clinical Trial.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Klein AL, Imazio M, Cremer P, Brucato A, Abbate A, Fang F, Insalaco A, LeWinter M, Lewis BS, Lin D, Luis SA, Nicholls SJ, Pano A, Wheeler A, Paolini JF; RHAPSODY Investigators. Klein AL, et al. N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200890 Clinical Trial.
392 results